The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems
Open accessAbstract
The successful clinical application of nucleic acid-based therapeutic strategies has been limited by the poor delivery efficiency achieved by existing vectors. The development of alternative delivery systems for improved biological activity is, therefore, mandatory. Since the seminal observations two decades ago that the Tat protein, and derived peptides, can translocate across biological membranes, cell-penetrating peptides (CPPs) have been considered one of the most promising tools to improve non-invasive cellular delivery of therapeutic molecules. Despite extensive research on the use of CPPs for this purpose, the exact mechanisms underlying their cellular uptake and that of peptide conjugates remain controversial. Over the last years, our research group has been focused on the S413-PV cell-penetrating peptide, a prototype of this class of peptides that results from the combination of 13-amino-acid cell penetrating sequence derived from the Dermaseptin S4 peptide with the SV40 large T antigen nuclear localization signal. By performing an extensive biophysical and biochemical characterization of this peptide and its analogs, we have gained important insights into the mechanisms governing the interaction of CPPs with cells and their translocation across biological membranes. More recently, we have started to explore this peptide for the intracellular delivery of nucleic acids (plasmid DNA, siRNA and oligonucleotides). In this review we discuss the current knowledge of the mechanisms responsible for the cellular uptake of cell-penetrating peptides, including the S413-PV peptide, and the potential of peptide-based formulations to mediate nucleic acid delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Lewin, M., Carlesso, N., Tung, C.-H., Tang, X.-W., Cory, D., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Green, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553
Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., & Lebleu, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209548200 · Cited by 1,446
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Tat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., & Huang, H. W. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75802-x · Cited by 1,114
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
A peptide carrier for the delivery of biologically active proteins into mammalian cells
Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1173 · Cited by 1,018
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
siRNAs: applications in functional genomics and potential as therapeutics
Dorsett, Y., & Tuschl, T. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1345 · Cited by 909
Multifunctional magnetic nanoparticles for targeted imaging and therapy
MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892
High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates
Josephson, L., Tung, C.-H., Moore, A., & Weissleder, R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980125h · Cited by 882
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01447-4 · Cited by 803
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Duchardt, F., Fotin‐Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00572.x · Cited by 771
Cellular Uptake of Arginine-Rich Peptides: Roles for Macropinocytosis and Actin Rearrangement
Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.010 · Cited by 752
Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., & Shai, Y. (1992) · Biochemistry · doi:10.1021/bi00164a017 · Cited by 687
Cationic TAT peptide transduction domain enters cells by macropinocytosis
Kaplan, I. M., Wadia, J. S., & Dowdy, S. F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.018 · Cited by 668
GUPTA, B., LEVCHENKO, T., & TORCHILIN, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.007 · Cited by 632
Nonviral gene therapy: promises and challenges
Li, S., & Huang, L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301110 · Cited by 614
Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., & Chernomordik, L. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m401604200 · Cited by 604
Towards safe, non-viral therapeutic gene expression in humans
Glover, D. J., Lipps, H. J., & Jans, D. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1577 · Cited by 598
Pooga, M., Soomets, U., Hällbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J.-X., Xu, X.-J., Wiesenfeld-Hallin, Z., et al. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-857 · Cited by 574
Nucleic-acid therapeutics: basic principles and recent applications
Opalinska, J. B., & Gewirtz, A. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd837 · Cited by 537
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
Morris, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2730 · Cited by 535
Transduction peptides: from technology to physiology
Joliot, A., & Prochiantz, A. (2004) · Nature Cell Biology · doi:10.1038/ncb0304-189 · Cited by 495
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
Deshayes, S., Morris, M. C., Divita, G., & Heitz, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5109-0 · Cited by 483
Simeoni, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg385 · Cited by 480
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475
SEGLEN, P. O., GRINDE, B., & SOLHEIM, A. E. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb12956.x · Cited by 469
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Stearylated Arginine-Rich Peptides: A New Class of Transfection Systems
Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H., & Sugiura, Y. (2001) · Bioconjugate Chemistry · doi:10.1021/bc015508l · Cited by 464
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers
Torchilin, V. P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.008 · Cited by 449
Cell-penetrating and cell-targeting peptides in drug delivery
Vivès, E., Schmidt, J., & Pèlegrin, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.03.001 · Cited by 441
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
WADIA, J., & DOWDY, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.005 · Cited by 428
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Patel, L. N., Zaro, J. L., & Shen, W.-C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9303-7 · Cited by 425
Cao, G., Pei, W., Ge, H., Liang, Q., Luo, Y., Sharp, F. R., Lu, A., Ran, R., Graham, S. H., & Chen, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05423.2002 · Cited by 419
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells
Muratovska, A., & Eccles, M. R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01505-9 · Cited by 390
Gleave, M. E., & Monia, B. P. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1631 · Cited by 384
Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells
Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381
A peptide nucleic acid–nuclear localization signal fusion that mediates nuclear transport of DNA
Brandén, L. J., Mohamed, A. J., & Smith, C. I. E. (1999) · Nature Biotechnology · doi:10.1038/11726 · Cited by 375
Pathway for Polyarginine Entry into Mammalian Cells
Fuchs, S. M., & Raines, R. T. (2004) · Biochemistry · doi:10.1021/bi035933x · Cited by 374
Cell‐penetrating peptides: from molecular mechanisms to therapeutics
Morris, M. C., Deshayes, S., Heitz, F., & Divita, G. (2008) · Biology of the Cell · doi:10.1042/bc20070116 · Cited by 361
Tan, M. L., Choong, P. F. M., & Dass, C. R. (2010) · Peptides · doi:10.1016/j.peptides.2009.10.002 · Cited by 350 · cited 4×
“Different types of lipid- and polymer-based vectors have been used for protein delivery, including liposomes, microparticles and nanoparticles, most of them with relatively poor efficiency [85,87].”
BackgroundInfluentialEguchi, A., Meade, B. R., Chang, Y.-C., Fredrickson, C. T., Willert, K., Puri, N., & Dowdy, S. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1541 · Cited by 340
Caveolae-Mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time
Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., & Beltram, F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00122-9 · Cited by 335
Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides
Lundberg, P., El‐Andaloussi, S., Sütlü, T., Johansson, H., & Langel, Ü. (2007) · The FASEB Journal · doi:10.1096/fj.06-6502com · Cited by 322
Martin, M. E., & Rice, K. G. (2007) · The AAPS Journal · doi:10.1208/aapsj0901003 · Cited by 319
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
Juliano, R., Bauman, J., Kang, H., & Ming, X. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900093r · Cited by 304
Cell surface adherence and endocytosis of protein transduction domains
Lundberg, M., Wikström, S., & Johansson, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00135-7 · Cited by 301
Lo, S. L., & Wang, S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.031 · Cited by 290
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283
Deletion analogues of transportan
Soomets, U., Lindgren, M., Gallet, X., Hällbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R., & Langel, Ü. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00216-9 · Cited by 283
Rudolph, C., Plank, C., Lausier, J., Schillinger, U., Müller, R. H., & Rosenecker, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211891200 · Cited by 275
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274
Heparan sulfate proteoglycan as a plasma membrane carrier
Belting, M. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00031-8 · Cited by 273
Fischer, R., Fotin‐Mleczek, M., Hufnagel, H., & Brock, R. (2005) · ChemBioChem · doi:10.1002/cbic.200500044 · Cited by 269
New Basic Membrane-Destabilizing Peptides for Plasmid-Based Gene Delivery in Vitro and in Vivo
Rittner, K., Benavente, A., Bompard-Sorlet, A., Heitz, F., Divita, G., Brasseur, R., & Jacobs, E. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0523 · Cited by 257
Targeted Delivery of Multifunctional Magnetic Nanoparticles
McCarthy, J. R., Kelly, K. A., Sun, E. Y., & Weissleder, R. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.153 · Cited by 255
Kim, W. J., Christensen, L. V., Jo, S., Yockman, J. W., Jeong, J. H., Kim, Y.-H., & Kim, S. W. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.022 · Cited by 251
Jearawiriyapaisarn, N., Moulton, H. M., Buckley, B., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P. L., & Kole, R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.120 · Cited by 244
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242
Cell-Penetrating Peptides: Mechanisms and Applications
El-Andaloussi, S., Holm, T., & Langel, U. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774580796 · Cited by 242
Tseng, Y.-L., Liu, J.-J., & Hong, R.-L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.864 · Cited by 241
Turner, J. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki991 · Cited by 233
Delivery Vehicles for Small Interfering RNA In Vivo
de Fougerolles, A. R. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.928 · Cited by 226
Kleemann, E., Neu, M., Jekel, N., Fink, L., Schmehl, T., Gessler, T., Seeger, W., & Kissel, T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.036 · Cited by 226
TAT Peptide Internalization: Seeking the Mechanism of Entry
Vives, E., Richard, J., Rispal, C., & Lebleu, B. (2003) · Current Protein & Peptide Science · doi:10.2174/1389203033487306 · Cited by 225
Yin, H., Moulton, H. M., Seow, Y., Boyd, C., Boutilier, J., Iverson, P., & Wood, M. J. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn293 · Cited by 224
A brief introduction to cell‐penetrating peptides
Lundberg, P., & Langel, Ü. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.630 · Cited by 223
Cell Entry of Arginine-rich Peptides Is Independent of Endocytosis
Ter-Avetisyan, G., Tünnemann, G., Nowak, D., Nitschke, M., Herrmann, A., Drab, M., & Cardoso, M. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805550200 · Cited by 221
Kogure, K., Moriguchi, R., Sasaki, K., Ueno, M., Futaki, S., & Harashima, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.024 · Cited by 218
Davidson, T. J., Harel, S., Arboleda, V. A., Prunell, G. F., Shelanski, M. L., Greene, L. A., & Troy, C. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3643-04.2004 · Cited by 216
Cell penetrating peptides: overview and applications to the delivery of oligonucleotides
Said Hassane, F., Saleh, A. F., Abes, R., Gait, M. J., & Lebleu, B. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0186-0 · Cited by 211
Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides
Moulton, H. M., Nelson, M. H., Hatlevig, S. A., Reddy, M. T., & Iversen, P. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034221g · Cited by 210
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene
Zhang, C., Tang, N., Liu, X., Liang, W., Xu, W., & Torchilin, V. P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.022 · Cited by 210
Comparison of Cellular Uptake Using 22 CPPs in 4 Different Cell Lines
Mueller, J., Kretzschmar, I., Volkmer, R., & Boisguerin, P. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800194e · Cited by 208
Ignatovich, I. A., Dizhe, E. B., Pavlotskaya, A. V., Akifiev, B. N., Burov, S. V., Orlov, S. V., & Perevozchikov, A. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301431200 · Cited by 205
Deshayes, S., Heitz, A., Morris, M. C., Charnet, P., Divita, G., & Heitz, F. (2004) · Biochemistry · doi:10.1021/bi035682s · Cited by 198
Abes, S., Moulton, H. M., Clair, P., Prevot, P., Youngblood, D. S., Wu, R. P., Iversen, P. L., & Lebleu, B. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.011 · Cited by 197
Vives, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.032 · Cited by 196
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
Crombez, L., Morris, M. C., Dufort, S., Aldrian-Herrada, G., Nguyen, Q., Mc Master, G., Coll, J.-L., Heitz, F., & Divita, G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp451 · Cited by 193
Octaarginine- and Octalysine-modified Nanoparticles Have Different Modes of Endosomal Escape
El-Sayed, A., Khalil, I. A., Kogure, K., Futaki, S., & Harashima, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709387200 · Cited by 191
A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction
Gros, E., Deshayes, S., Morris, M. C., Aldrian-Herrada, G., Depollier, J., Heitz, F., & Divita, G. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.006 · Cited by 189
Veldhoen, S., Laufer, S. D., Trampe, A., & Restle, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl941 · Cited by 188
Mäe, M., EL Andaloussi, S., Lundin, P., Oskolkov, N., Johansson, H. J., Guterstam, P., & Langel, Ü. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.11.025 · Cited by 187
Simões, S., Slepushkin, V, Gaspar, R., Pedroso de Lima, M., & Düzgüneş, N. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300674 · Cited by 186
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy
Deshayes, S., Morris, M., Heitz, F., & Divita, G. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.005 · Cited by 185
Distinct Uptake Routes of Cell-Penetrating Peptide Conjugates
Lundin, P., Johansson, H., Guterstam, P., Holm, T., Hansen, M., Langel, Ü., & EL Andaloussi, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800212j · Cited by 183
A novel potent strategy for gene delivery using a single peptide vector as a carrier
Morris, M. C., Chaloin, L., Mery, J., Heitz, F., & Divita, G. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.17.3510 · Cited by 182
In Vivo Application of RNA Interference: From Functional Genomics to Therapeutics
Lu, P. Y., Xie, F., & Woodle, M. C. (2005) · Advances in Genetics · doi:10.1016/s0065-2660(05)54006-9 · Cited by 179
Improvement through novel chemical modifications
Kurreck, J. (2003) · Cited by 179
Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery
Khalil, I. A., Kogure, K., Futaki, S., Hama, S., Akita, H., Ueno, M., Kishida, H., Kudoh, M., Mishina, Y., Kataoka, K., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302910 · Cited by 178
Zeineddine, D., Papadimou, E., Chebli, K., Gineste, M., Liu, J., Grey, C., Thurig, S., Behfar, A., Wallace, V. A., Skerjanc, I. S., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.07.013 · Cited by 178
Protein Transduction: Cell Penetrating Peptides and Their Therapeutic Applications
Wagstaff, K., & Jans, D. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776872871 · Cited by 176
Cell penetrating peptide conjugates of steric block oligonucleotides
Lebleu, B., Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., & Gait, M. J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.002 · Cited by 175
Meade, B. R., & Dowdy, S. F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.004 · Cited by 174
The use of cell-penetrating peptides as a tool for gene regulation
Järver, P., & Langel, Ü. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03042-9 · Cited by 174
Nuclear Targeting of Macromolecular Polyanions by an HIV-Tat Derived Peptide
Sandgren, S., Cheng, F., & Belting, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205395200 · Cited by 174
Magzoub, M., Eriksson, L. E. G., & Gräslund, A. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00373-5 · Cited by 174
Khalil, I., Futaki, S., Niwa, M., Baba, Y., Kaji, N., Kamiya, H., & Harashima, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302128 · Cited by 166
Berlose, J., Convert, O., Derossi, D., Brunissen, A., & Chassaing, G. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0372r.x · Cited by 163
Simões, S., Slepushkin, V, Pires, P., Gaspar, R., de Lima, M. P., & Düzgüneş, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301015 · Cited by 161
Self-citationTargeting tumors with non-viral gene delivery systems
Ogris, M., & Wagner, E. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02243-2 · Cited by 158
Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide
Abes, S., Turner, J. J., Ivanova, G. D., Owen, D., Williams, D., Arzumanov, A. A., Clair, P., Gait, M. J., & Lebleu, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm418 · Cited by 157
The use of cell-penetrating peptides for drug delivery
Temsamani, J., & Vidal, P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03279-9 · Cited by 153
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA
Turner, J. J., Jones, S. W., Fabani, M. M., Ivanova, G. D., Arzumanov, A. A., & Gait, M. J. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.10.003 · Cited by 151
Matsuzaki, K., Sugishita, K.-I., & Miyajima, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00443-3 · Cited by 150
Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates
Abes, S., Williams, D., Prévôt, P., Thierry, A. R., Gait, M. J., & Lebleu, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.026 · Cited by 149
Intracellular Delivery of a Tat-eGFP Fusion Protein into Muscle Cells
Caron, N. J., Torrente, Y., Camirand, G., Bujold, M., Chapdelaine, P., Leriche-Guérin, K., Bresolin, N., & Tremblay, J. P. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0279 · Cited by 146
Mi, Z., Mai, J., Lü, X., & Robbins, P. D. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0137 · Cited by 145
Shiraishi, T., Pankratova, S., & Nielsen, P. E. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.06.009 · Cited by 144
Induction of splice correction by cell‐penetrating peptide nucleic acids
Andaloussi, S. E., Johansson, H. J., Lundberg, P., & Langel, Ü. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.950 · Cited by 141
Revised Role of Glycosaminoglycans in TAT Protein Transduction Domain-mediated Cellular Transduction
Gump, J. M., June, R. K., & Dowdy, S. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021964 · Cited by 139
Jin, L. H., Bahn, J. H., Eum, W. S., Kwon, H. Y., Jang, S. H., Han, K. H., Kang, T., Won, M. H., Kang, J. H., Cho, S. W., et al. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00734-1 · Cited by 137
Yin, H., Moulton, H. M., Betts, C., Seow, Y., Boutilier, J. K., Iverson, P. L., & Wood, M. J. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp395 · Cited by 137
alpha-2,8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide.
Joliot, A., Triller, A., Volovitch, M., Pernelle, C., & Prochiantz, A. (1991) · PubMed · Cited by 135
A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
Morris, M. C., Gros, E., Aldrian, G., Choob, M. V., Archdeacon, J., Heitz, F., & Divita, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm053 · Cited by 129
Lehto, T., Abes, R., Oskolkov, N., Suhorutšenko, J., Copolovici, D. M., Mäger, I., Viola, J. R., Simonson, O. E., Ezzat, K., & Guterstam, P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.028 · Cited by 127
Joanne, P., Galanth, C., Goasdoué, N., Nicolas, P., Sagan, S., Lavielle, S., Chassaing, G., Amri, C. E., & Alves, I. D. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.05.001 · Cited by 121
On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids
Deshayes, S., Gerbal‐Chaloin, S., Morris, M. C., Aldrian, G., Charnet, P., Divita, G., & Heitz, F. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.09.010 · Cited by 120
Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins
Caron, N. J., Quenneville, S., & Tremblay, J. P. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.180 · Cited by 119
siRNA delivery using peptide transduction domains
Eguchi, A., & Dowdy, S. F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.009 · Cited by 115
Hyndman, L., Lemoine, J. L., Huang, L., Porteous, D. J., Boyd, A., & Nan, X. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.023 · Cited by 115
A non-covalent peptide-based strategy for siRNA delivery
Crombez, L., Charnet, A., Morris, M. C., Aldrian, G., Heitz, F., & Divita, G. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350044 · Cited by 102
On the mechanisms of the internalization of S413-PV cell-penetrating peptide
Mano, M., Teodósio, C., Paiva, A. A., Simões, S., & de Lima, M. C. P. (2005) · Biochemical Journal · doi:10.1042/bj20050577 · Cited by 94
Self-citationRecent Developments in Peptide-Based Nucleic Acid Delivery
Veldhoen, S., Laufer, S. D., & Restle, T. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9071276 · Cited by 88
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies
Abes, R., Moulton, H. M., Clair, P., Yang, S., Abes, S., Melikov, K., Prévôt, P., Youngblood, D. S., Iversen, P. L., Chernomordik, L., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn541 · Cited by 88
Jones, A. T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.046 · Cited by 84
Analytical Methods for the Characterization of Cationic Lipid–Nucleic Acid Complexes
Ferrari, M. E., Nguyen, C. M., Zelphati, O., Tsai, Y.-L., & Felgner, P. L. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.3-341 · Cited by 83
Wolf, Y., Pritz, S., Abes, S., Bienert, M., Lebleu, B., & Oehlke, J. (2006) · Biochemistry · doi:10.1021/bi0606896 · Cited by 81
Endoh, T., Sisido, M., & Ohtsuki, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800020n · Cited by 81
Kogure, K., Akita, H., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.018 · Cited by 78
Evaluation of transportan 10 in PEI mediated plasmid delivery assay
Kilk, K., Andaloussi, S. E., Järver, P., Meikas, A., Valkna, A., Bartfai, T., Kogerman, P., METSIS, M. L., & Langel, Ü. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.006 · Cited by 75
RNA Interference as A Gene-Specific Approach for Molecular Medicine
Grünweller, A., & Hartmann, R. K. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774933489 · Cited by 72
Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes
Vandenbroucke, R. E., Smedt, S. C. D., Demeester, J., & Sanders, N. N. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.006 · Cited by 69
Photo‐acceleration of protein release from endosome in the protein transduction system
Matsushita, M., Noguchi, H., Lü, Y.-F., Tomizawa, K., Michiue, H., Li, S., Hirose, K., Bonner‐Weir, S., & Matsui, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.033 · Cited by 69
Maiolo, J. R., Ottinger, E. A., & Ferrer, M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044867z · Cited by 67
Abes, S., Moulton, H. M., Turner, J., Clair, P., Richard, J., Iversen, P. L., Gait, M. J., & Lebleu, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350053 · Cited by 62
Morris, M. C., Chaloin, L., Choob, M. V., Archdeacon, J., Heitz, F., & Divita, G. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302235 · Cited by 59
Laufer, S., & Restle, T. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898806 · Cited by 52
Oehlke, J., Wallukat, G., Wolf, Y., Ehrlich, A., Wiesner, B., Berger, H., & Bienert, M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04236.x · Cited by 44
Trabulo, S. M. D., Mano, M., Faneca, H., Cardoso, A. L., Duarte, S., Henriques, A., Paiva, A. A., Gomes, P. A. C., Simões, S., & de Lima, M. C. P. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1247 · Cited by 40
Self-citationTrabulo, S. M. D., Resina, S., Simões, S., Lebleu, B., & de Lima, M. C. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.021 · Cited by 38
Self-citationMacKay, J. A., Li, W., Huang, Z. R., Dy, E. E., Huynh, G. H., Tihan, T., Collins, R., Deen, D. F., & Szoka, F. C. (2008) · Molecular Therapy · doi:10.1038/mt.2008.36 · Cited by 38
Mano, M., Henriques, A., Paiva, A. A., PRIETO, M. J. E., Gavilanes, F., Simões, S., & de Lima, M. C. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.014 · Cited by 33
Self-citationMano, M., Henriques, A., Paiva, A. A., PRIETO, M. J. E., Gavilanes, F., Simões, S., & de Lima, M. C. P. (2007) · Journal of Peptide Science · doi:10.1002/psc.842 · Cited by 25
Self-citationPhotochemically Induced Gene Silencing Using PNA-Peptide Conjugates
Bøe, S. L., & Hovig, E. J. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.145 · Cited by 23
Cited by
Cell-penetrating peptides: breaking through to the other side
Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 670
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Internalization mechanisms of cell-penetrating peptides
Ruseska, I., & Zimmer, A. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.10 · Cited by 436
Enzyme responsive drug delivery systems in cancer treatment
Shahriari, M., Zahiri, M., Abnous, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.004 · Cited by 415
Metadata
- Authors
- Trabulo, S., Cardoso, A. L., Mano, M., & De Lima, M. C. P.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2010-03-30
- Volume
- 3
- Issue
- 4
- Pages
- 961-993
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W2135986253
- Cited by
- 290
- References
- 163
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.